PHOX2B: A Potential Drug Target for Neuroblastomas (G8929)

Target Name: PHOX2B

NCBI ID: G8929

PHOX2B: A Potential Drug Target for Neuroblastomas

PHOX2B, also known as neuroblastoma Phox, is a protein that is expressed in a variety of tissues, including the brain, and is known to play a role in the development and progression of neuroblastomas. While more research is needed to fully understand its role, PHOX2B has potential as a drug target or biomarker in the treatment of neuroblastomas.

Neuroblastomas are a type of cancer that arises from neural stem cells, which are responsible for the development and maintenance of all of the tissues in the nervous system. When these stem cells divide out of control, they can form a neuroblastoma. Treatment for neuroblastomas is often difficult and effective, with a five-year survival rate of only around 15%.

One potential approach to treating neuroblastomas is to target the PHOX2B protein. PHOX2B is a transcription factor that has been shown to play a role in the development and progression of neuroblastomas. It has been shown to promote the expression of genes that are involved in cell proliferation and survival, and has been linked to the development of neuroblastoma.

In addition, PHOX2B has also been shown to play a role in the regulation of pain. It has been shown to reduce the sensitivity to pain in animals with neuroblastomas, and has been linked to the development of neuroblastoma in animal models of pain.

Furthermore, PHOX2B has also been shown to play a role in the regulation of stem cell proliferation. It has been shown to inhibit the proliferation of stem cells, which may have implications for the development and treatment of neuroblastomas.

In conclusion, PHOX2B is a protein that has potential as a drug target or biomarker in the treatment of neuroblastomas. Further research is needed to fully understand its role and to develop effective treatments.

Protein Name: Paired Like Homeobox 2B

Functions: Involved in the development of several major noradrenergic neuron populations, including the locus coeruleus. Transcription factor which could determine a neurotransmitter phenotype in vertebrates. Enhances second-messenger-mediated activation of the dopamine beta-hydrolase and c-fos promoters, and of several enhancers including cAMP-response element and serum-response element

More Common Targets